QuidelOrtho CLO RSUs Vest, Shares Withheld for Taxes

QuidelOrtho Corp’s Chief Legal Officer, Michelle A. Hodges, reported equity award activity involving restricted stock units and common shares.

Accepted by SEC EDGAR 02/02/2026 - 07:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

QuidelOrtho Corp’s Chief Legal Officer, Michelle A. Hodges, reported equity award activity involving restricted stock units and common shares. On January 29, 2026, 7,836 restricted stock units converted into 7,836 shares of common stock at $0, reflecting the vesting of a prior award.

To cover tax withholding on this release, 3,072 common shares were withheld at a price of $27.41 per share. After these transactions, Hodges directly owned 37,360 shares of QuidelOrtho common stock and 15,673 restricted stock units, each representing the right to receive one share if and when it vests.

Insider Trade Summary

7,836 shares exercised/converted

Exercise 3 txns

Insider Hodges Michelle A

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	7,836	$0.00	$0.00
Grant/Award	Common Stock	7,836	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,072	$27.41	$84K

Holdings After Transaction: Restricted Stock Units — 15,673 contracts (Direct); Common Stock — 37,360 shares (Direct)

Holdings Before and After: Restricted Stock Units, 23,509 to 15,673 contracts (Direct); Common Stock, 32,596 to 37,360 shares (Direct)

Footnotes (5)

1. F1. Reflects release of restricted stock units that were previously reported on a Form 4.
2. F2. The amount of shares beneficially owned following this transaction includes an additional 561 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
3. F3. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
4. F4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
5. F5. 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hodges Michelle A

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		A		7,836(1)	A	$0	40,432(2)	D
Common Stock	01/29/2026		F		3,072(3)	D	$27.41	37,360	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(4)	01/29/2026		M			7,836	(5)	(5)	Common Stock	7,836	$0	15,673	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. The amount of shares beneficially owned following this transaction includes an additional 561 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.

3. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

5. 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.